Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bleyer

Showing results (591-600 of 664) with videos related to

Pageof 67
Sort By:
Pediatric Blood & Cancer|February 11, 2023
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use itPenelope Brock, Annelot Meijer, Per Kogner, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 9, 2010
Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysisBarry I Freedman, Rajeev N Shenoy, Jonathan A Planer, et al.
Kidney International|April 21, 2023
Novel MUC1 variant identified by massively parallel sequencing explains interstitial kidney disease in a large Dutch familyAmber de Haan, Albertien M van Eerde, Mark Eijgelsheim, et al.
Frontiers in Immunology|March 20, 2024
The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancerAllison Voisin, Maud Plaschka, Marlène Perrin-Niquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Obesity and outcome in pediatric acute lymphoblastic leukemiaAnna M Butturini, Frederick J Dorey, Beverly J Lange, et al.
Antioxidants (Basel, Switzerland)|April 28, 2023
Mitochondrial ROS Triggers KIN Pathogenesis in FAN1-Deficient KidneysMerlin Airik, Haley Arbore, Elizabeth Childs, et al.
Journal for Immunotherapy of Cancer|November 8, 2023
MDR1-EXPRESSING CD4<sup>+</sup> T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSEAnthony Di Roio, Margaux Hubert, Laurie Besson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 11, 2014
Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1Anthony J Bleyer, Stanislav Kmoch, Corinne Antignac, et al.
Leukemia & Lymphoma|November 9, 2017
Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trialsMichael J Burke, Meenakshi Devidas, Kelly Maloney, et al.
American Journal of Hematology|July 31, 2018
Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimensStuart E Siegel, Anjali Advani, Nita Seibel, et al.
Pageof 67

Showing results (591-600 of 664) with videos related to

Sort By:
Pageof 67
Pediatric Blood & Cancer|February 11, 2023
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use itPenelope Brock, Annelot Meijer, Per Kogner, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 9, 2010
Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysisBarry I Freedman, Rajeev N Shenoy, Jonathan A Planer, et al.
Kidney International|April 21, 2023
Novel MUC1 variant identified by massively parallel sequencing explains interstitial kidney disease in a large Dutch familyAmber de Haan, Albertien M van Eerde, Mark Eijgelsheim, et al.
Frontiers in Immunology|March 20, 2024
The NF-κB RelA transcription factor is not required for CD8+ T-cell function in acute viral infection and cancerAllison Voisin, Maud Plaschka, Marlène Perrin-Niquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Obesity and outcome in pediatric acute lymphoblastic leukemiaAnna M Butturini, Frederick J Dorey, Beverly J Lange, et al.
Antioxidants (Basel, Switzerland)|April 28, 2023
Mitochondrial ROS Triggers KIN Pathogenesis in FAN1-Deficient KidneysMerlin Airik, Haley Arbore, Elizabeth Childs, et al.
Journal for Immunotherapy of Cancer|November 8, 2023
MDR1-EXPRESSING CD4<sup>+</sup> T CELLS WITH TH1.17 FEATURES RESIST TO NEOADJUVANT CHEMOTHERAPY AND ARE ASSOCIATED WITH BREAST CANCER CLINICAL RESPONSEAnthony Di Roio, Margaux Hubert, Laurie Besson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 11, 2014
Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1Anthony J Bleyer, Stanislav Kmoch, Corinne Antignac, et al.
Leukemia & Lymphoma|November 9, 2017
Severe pegaspargase hypersensitivity reaction rates (grade ≥3) with intravenous infusion vs. intramuscular injection: analysis of 54,280 doses administered to 16,534 patients on children's oncology group (COG) clinical trialsMichael J Burke, Meenakshi Devidas, Kelly Maloney, et al.
American Journal of Hematology|July 31, 2018
Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimensStuart E Siegel, Anjali Advani, Nita Seibel, et al.
Pageof 67